Advertisement

Cholinesterase Inhibitors Beneficial for Dementia With Lewy Bodies

0

Use of ChEIs significantly slowed cognitive decline at follow-ups compared with memantine and nonuse

Ubrogepant Administered During Prodrome Beneficial for Migraine

0

Greater ability to function normally, greater reduction in activity limitations, and greater rate of satisfaction seen with medication

Lecanemab-Labeled Amyloid Plaques Identified in Down Syndrome

0

Extensive binding of lecanemab to brain blood vessels observed in Down syndrome postmortem brain tissue analysis

Sensitivity, Specificity of M-CHAT-R/F for Autism Acceptable for Preemies

0

Highest positive predictive value seen for children born extremely preterm and those born at term

Team-Based Documentation Can Increase Visit Volume, Cut Documentation Time

0

High-intensity adopters had reduction in documentation for full postadoption periods and following learning period

Risk for Dementia Similar With SGLT2 Inhibitors, Dulaglutide in T2DM

0

Estimated risk difference varied from −2.45 to 0.63 percentage points with SGLT2 versus dulaglutide among older adults

Awareness of Unruptured Aneurysm Diagnosis Increases Risk for Mental Illness

0

Incidence rate of mental illness higher among those with UIA, especially in younger age groups

‘Bed Rotting’ and Other TikTok Sleep Trends Carry Risks

0

About 55 percent of Gen Z says they have tried a sleep trend they came across on TikTok and other platforms

Cognitive Difficulties Tied to Lower Return to Work After Breast Cancer

0

Return to work two years after diagnosis associated with higher cognitive speed performance before and after cancer treatment

Index of Symptoms Can Identify Long COVID in Children, Adolescents

0

Index emphasizes distinct symptoms in children and adolescents, and is linked to poorer overall health, QoL